New York State Common Retirement Fund Purchases 17,278 Shares of Integer Holdings Corporation (NYSE:ITGR)

New York State Common Retirement Fund boosted its stake in Integer Holdings Corporation (NYSE:ITGR - Free Report) by 7.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 249,847 shares of the medical equipment provider's stock after buying an additional 17,278 shares during the quarter. New York State Common Retirement Fund owned approximately 0.72% of Integer worth $29,484,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in ITGR. Lee Danner & Bass Inc. purchased a new stake in Integer in the 4th quarter worth approximately $27,000. AdvisorNet Financial Inc bought a new position in shares of Integer during the 1st quarter valued at $28,000. Opal Wealth Advisors LLC bought a new position in shares of Integer during the 1st quarter valued at $28,000. Bessemer Group Inc. raised its holdings in shares of Integer by 73.1% during the 1st quarter. Bessemer Group Inc. now owns 296 shares of the medical equipment provider's stock valued at $35,000 after purchasing an additional 125 shares in the last quarter. Finally, Sterling Capital Management LLC raised its holdings in shares of Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock valued at $45,000 after purchasing an additional 279 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company's stock.

Integer Trading Down 2.5%

Shares of ITGR traded down $2.88 on Friday, reaching $111.76. 193,841 shares of the company's stock were exchanged, compared to its average volume of 389,136. Integer Holdings Corporation has a 12 month low of $104.93 and a 12 month high of $146.36. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78. The stock has a market capitalization of $3.90 billion, a P/E ratio of 52.99, a price-to-earnings-growth ratio of 1.01 and a beta of 0.98. The business has a 50 day moving average price of $119.76 and a two-hundred day moving average price of $124.59.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer had a net margin of 4.38% and a return on equity of 11.95%. The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.14 earnings per share. Research analysts anticipate that Integer Holdings Corporation will post 6.01 earnings per share for the current year.

Insider Buying and Selling

In related news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total transaction of $41,751,550.75. Following the completion of the transaction, the chief executive officer owned 47,000 shares in the company, valued at approximately $5,788,990. This represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the transaction, the director owned 22,170 shares of the company's stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 362,434 shares of company stock worth $44,577,115. 2.16% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a report on Monday, May 19th. KeyCorp decreased their target price on shares of Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Truist Financial set a $150.00 price target on shares of Integer and gave the company a "buy" rating in a research report on Friday, April 25th. Citigroup upgraded shares of Integer from a "hold" rating to a "strong-buy" rating and boosted their price target for the company from $133.00 to $140.00 in a research report on Thursday, May 22nd. Finally, Benchmark dropped their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $146.25.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.